11.01.2021 • News

Moderna Appoints Chief Commercial Officer

As it rolls out an increasing number of doses of its mRNA-based Covid-19 vaccine, US biotech Moderna has appointed a pharma industry veteran to spearhead the effort. Corinne Le Goff will take up the position on Jan. 19.

Le Goff’s last role was senior vice president of Amgen and president of its US business. The pharmacist by training is credited with overseeing Amgen’s Otezla integration after the company acquired the drug from Celgene in 2019, along with boosting sales of cholesterol med Repatha and migraine launch Aimovig.

“Corinne is joining us at an important time as we launch our Covid-19 vaccine, prepare to start the Phase 3 study of our CMV vaccine and pivot to a commercial-stage company,” Moderna CEO Stéphane Bancel said in a statement.

Author: Dede Williams, Freelance Journalist

As it rolls out an increasing number of doses of its mRNA-based Covid-19... — As it rolls out an increasing number of doses of its mRNA-based Covid-19 vaccine, US biotech Moderna has appointed a pharma industry veteran to spearhead the effort. Corinne Le Goff will take up the position on Jan. 19. (c) JULIE BOURGES

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Special Issue

Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.